Annual Cash & Cash Equivalents
$170.20 M
+$107.67 M+172.21%
December 31, 2023
Summary
- As of February 12, 2025, AMLX annual cash & cash equivalents is $170.20 million, with the most recent change of +$107.67 million (+172.21%) on December 31, 2023.
- During the last 3 years, AMLX annual cash & cash equivalents has risen by +$157.32 million (+1221.74%).
- AMLX annual cash & cash equivalents is now at all-time high.
Performance
AMLX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$71.84 M
-$3.16 M-4.21%
September 30, 2024
Summary
- As of February 12, 2025, AMLX quarterly cash and cash equivalents is $71.84 million, with the most recent change of -$3.16 million (-4.21%) on September 30, 2024.
- Over the past year, AMLX quarterly cash and cash equivalents has dropped by -$63.42 million (-46.89%).
- AMLX quarterly cash and cash equivalents is now -71.00% below its all-time high of $247.76 million, reached on June 30, 2023.
Performance
AMLX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AMLX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +172.2% | -46.9% |
| 3 y3 years | +1221.7% | -46.9% |
| 5 y5 years | +5453.1% | -46.9% |
AMLX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +239.1% | -71.0% | +43.1% |
| 5 y | 5-year | at high | +5453.1% | -71.0% | +457.9% |
| alltime | all time | at high | +5453.1% | -71.0% | +457.9% |
Amylyx Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $71.84 M(-4.2%) |
| Jun 2024 | - | $75.00 M(-56.0%) |
| Mar 2024 | - | $170.55 M(+0.2%) |
| Dec 2023 | $170.20 M(+172.2%) | $170.20 M(+25.8%) |
| Sep 2023 | - | $135.26 M(-45.4%) |
| Jun 2023 | - | $247.76 M(+116.3%) |
| Mar 2023 | - | $114.56 M(+83.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $62.53 M(+24.6%) | $62.53 M(-42.0%) |
| Sep 2022 | - | $107.73 M(+59.7%) |
| Jun 2022 | - | $67.44 M(-38.9%) |
| Mar 2022 | - | $110.40 M(+120.0%) |
| Dec 2021 | $50.19 M(+289.8%) | $50.19 M(-34.5%) |
| Sep 2021 | - | $76.68 M(+495.5%) |
| Dec 2020 | $12.88 M(+320.1%) | $12.88 M |
| Dec 2019 | $3.06 M | - |
FAQ
- What is Amylyx Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Amylyx Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Amylyx Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of AMLX is $170.20 M
What is the all time high annual cash & cash equivalents for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high annual cash & cash equivalents is $170.20 M
What is Amylyx Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, AMLX annual cash & cash equivalents has changed by +$107.67 M (+172.21%)
What is Amylyx Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AMLX is $71.84 M
What is the all time high quarterly cash and cash equivalents for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high quarterly cash and cash equivalents is $247.76 M
What is Amylyx Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, AMLX quarterly cash and cash equivalents has changed by -$63.42 M (-46.89%)